AVBP compared with CMPX: revenue, margins and what each company keeps, and the suppliers and customers both name

AVBPArriVent BioPharma, Inc.

Mkt capRevenueRevenue

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AVBPArriVent BioPharma, Inc.

CMPXCompass Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AVBP

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±16.3%▼−4.64%×0.28

May 12 '26±11.3%▼−0.17%×0.02

Q1 FY26±25.8%▼−7.21%×0.28

Nov 10 '25±21.0%▲+3.08%×0.15

CMPX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+5.29%—

May 5 '26±16.1%▲+0.52%×0.03

= impliedAVBP realized, solidCMPX realized, hatchedOne scale, both sides: full bar = 53%× = |realized| ÷ impliedSource: market data

Q1 FY26

±52.0%

▼−2.81%

×0.05

Jan 6 '26±33.6%▼−1.60%×0.05

AVBPArriVent BioPharma, Inc.

14.93▼−6.41%· post 14.72

Mkt cap$707.9MRevenue—

CMPXCompass Therapeutics, Inc.

0.79▲+3.85%· post 0.79

ClosedOct 30 '26

Mkt cap$141.6MRevenue$850,000Q2 FY24

Compare

ClosedOct 30 '26

AVBPArriVent BioPharma, Inc.

CMPXCompass Therapeutics, Inc.

14.93▼−6.41%post 14.72

Price

0.79▲+3.85%post 0.79

$707.9M

Mkt cap

$141.6M

—

Revenue

$850,000Q2 FY24

AVBP14.93▼−6.41%vsCMPX0.79▲+3.85%ClosedOct 30 '26